LMR Partners’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

LMR Partners’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$2.71M	–	1226
2023 Q3	$2.71M	Hold	250,000	–	–	0.03%	353
2023 Q2	$2.66M	Hold	250,000	–	–	0.03%	314
2023 Q1	$2.61M	Hold	250,000	–	–	0.04%	379
2022 Q4	$2.56M	Buy	+250,000	New	+$2.54M	0.04%	447

LMR Partners's BIOS Position: Q4 2023 in Review

LMR Partners sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 250,000 shares — an estimated $2.71M sold.

LMR Partners first reported a position in BIOS in Q4 2022 and held it in 4 quarters. The position peaked at $2.71M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

LMR Partners reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
LMR Partners sold 250,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.71M.
LMR Partners first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 4 quarters.
LMR Partners's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $2.71M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on LMR Partners's 13F filing for Q4 2023, filed 14 Feb 2024.